120 related articles for article (PubMed ID: 38493315)
1. Diagnostic Value of GSTP1, RASSF1, AND RASSF2 Methylation in Serum of Prostate Cancer Patients.
Aykanli E; Arisan S; Arisan ED; Yavuzsan AH
Urol J; 2024 May; 21(3):182-188. PubMed ID: 38493315
[TBL] [Abstract][Full Text] [Related]
2. Frequent methylation of RASSF1 and RARB in urine sediments from patients with early stage prostate cancer.
Daniūnaitė K; Berezniakovas A; Jankevičius F; Laurinavičius A; Lazutka JR; Jarmalaitė S
Medicina (Kaunas); 2011; 47(3):147-53. PubMed ID: 21822036
[TBL] [Abstract][Full Text] [Related]
3. Prostate cancer molecular detection in plasma samples by glutathione S-transferase P1 (GSTP1) methylation analysis.
Dumache R; Puiu M; Motoc M; Vernic C; Dumitrascu V
Clin Lab; 2014; 60(5):847-52. PubMed ID: 24839830
[TBL] [Abstract][Full Text] [Related]
4. The investigation of GSTP1, APC and RASSF1 gene promoter hypermethylation in urine DNA of prostate-diseased patients.
Haluskova J; Lachvac L; Nagy V
Bratisl Lek Listy; 2015; 116(2):79-82. PubMed ID: 25665470
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of GSTP1 and APC methylation as indicators for repeat biopsy in a high-risk cohort of men with negative initial prostate biopsies.
Trock BJ; Brotzman MJ; Mangold LA; Bigley JW; Epstein JI; McLeod D; Klein EA; Jones JS; Wang S; McAskill T; Mehrotra J; Raghavan B; Partin AW
BJU Int; 2012 Jul; 110(1):56-62. PubMed ID: 22077694
[TBL] [Abstract][Full Text] [Related]
6. Using Genetic and Epigenetic Markers to Improve Differential Diagnosis of Prostate Cancer and Benign Prostatic Hyperplasia by Noninvasive Methods in Mexican Patients.
Sánchez BE; Aguayo A; Martínez B; Rodríguez F; Marmolejo M; Svyryd Y; Luna L; Muñoz LA; Jiménez MA; Sotomayor M; Vargas V F; Mutchinick OM
Clin Genitourin Cancer; 2018 Aug; 16(4):e867-e877. PubMed ID: 29571584
[TBL] [Abstract][Full Text] [Related]
7. Molecular Diagnostic of Prostate Cancer From Body Fluids Using Methylation-Specific PCR (MS-PCR) Method.
Minciu R; Dumache R; Gheorghe P; Daminescu L; Rogobete AF; Ionescu D
Clin Lab; 2016; 62(6):1183-6. PubMed ID: 27468582
[TBL] [Abstract][Full Text] [Related]
8. GCPII modulates oxidative stress and prostate cancer susceptibility through changes in methylation of RASSF1, BNIP3, GSTP1 and Ec-SOD.
Divyya S; Naushad SM; Murthy PV; Reddy ChR; Kutala VK
Mol Biol Rep; 2013 Oct; 40(10):5541-50. PubMed ID: 23979608
[TBL] [Abstract][Full Text] [Related]
9. Risk score predicts high-grade prostate cancer in DNA-methylation positive, histopathologically negative biopsies.
Van Neste L; Partin AW; Stewart GD; Epstein JI; Harrison DJ; Van Criekinge W
Prostate; 2016 Sep; 76(12):1078-87. PubMed ID: 27121847
[TBL] [Abstract][Full Text] [Related]
10. CpG island hypermethylation in cell-free serum DNA identifies patients with localized prostate cancer.
Ellinger J; Haan K; Heukamp LC; Kahl P; Büttner R; Müller SC; von Ruecker A; Bastian PJ
Prostate; 2008 Jan; 68(1):42-9. PubMed ID: 18004747
[TBL] [Abstract][Full Text] [Related]
11. Measurement of GSTP1 promoter methylation in body fluids may complement PSA screening: a meta-analysis.
Wu T; Giovannucci E; Welge J; Mallick P; Tang WY; Ho SM
Br J Cancer; 2011 Jun; 105(1):65-73. PubMed ID: 21654682
[TBL] [Abstract][Full Text] [Related]
12. A tissue biopsy-based epigenetic multiplex PCR assay for prostate cancer detection.
Van Neste L; Bigley J; Toll A; Otto G; Clark J; Delrée P; Van Criekinge W; Epstein JI
BMC Urol; 2012 Jun; 12():16. PubMed ID: 22672250
[TBL] [Abstract][Full Text] [Related]
13. GSTP1 methylation in cancer: a liquid biopsy biomarker?
Gurioli G; Martignano F; Salvi S; Costantini M; Gunelli R; Casadio V
Clin Chem Lab Med; 2018 Apr; 56(5):702-717. PubMed ID: 29305565
[TBL] [Abstract][Full Text] [Related]
14. [GSTP1, APC and RASSF1 gene methylation in prostate cancer samples: comparative analysis of MS-HRM method and Infinium HumanMethylation450 BeadChip beadchiparray diagnostic value].
Skorodumova LO; Babalyan KA; Sultanov R; Vasiliev AO; Govorov AV; Pushkar DY; Prilepskaya EA; Danilenko SA; Generozov EV; Larin AK; Kostryukova ES; Sharova EI
Biomed Khim; 2016 Nov; 62(6):708-714. PubMed ID: 28026816
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of DNA methylation in multifocal prostate cancer.
Serenaite I; Daniunaite K; Jankevicius F; Laurinavicius A; Petroska D; Lazutka JR; Jarmalaite S
Virchows Arch; 2015 Jan; 466(1):53-9. PubMed ID: 25369892
[TBL] [Abstract][Full Text] [Related]
16. Urinary DNA methylation biomarkers for prediction of prostate cancer upgrading and upstaging.
Bakavicius A; Daniunaite K; Zukauskaite K; Barisiene M; Jarmalaite S; Jankevicius F
Clin Epigenetics; 2019 Aug; 11(1):115. PubMed ID: 31383039
[TBL] [Abstract][Full Text] [Related]
17. Cell-free DNA and RNA in plasma as a new molecular marker for prostate and breast cancer.
Papadopoulou E; Davilas E; Sotiriou V; Georgakopoulos E; Georgakopoulou S; Koliopanos A; Aggelakis F; Dardoufas K; Agnanti NJ; Karydas I; Nasioulas G
Ann N Y Acad Sci; 2006 Sep; 1075():235-43. PubMed ID: 17108217
[TBL] [Abstract][Full Text] [Related]
18. Combined hypermethylation of APC and GSTP1 as a molecular marker for prostate cancer: quantitative pyrosequencing analysis.
Yoon HY; Kim SK; Kim YW; Kang HW; Lee SC; Ryu KH; Shon HS; Kim WJ; Kim YJ
J Biomol Screen; 2012 Aug; 17(7):987-92. PubMed ID: 22511308
[TBL] [Abstract][Full Text] [Related]
19. Methylation analysis of BRCA1, RASSF1, GSTP1 and EPHB2 promoters in prostate biopsies according to different degrees of malignancy.
Rabiau N; Thiam MO; Satih S; Guy L; Kemeny JL; Boiteux JP; Fontana L; Bignon YJ; Bernard-Gallon D
In Vivo; 2009; 23(3):387-91. PubMed ID: 19454503
[TBL] [Abstract][Full Text] [Related]
20. GSTP1 hypermethylation as a molecular marker in the diagnosis of prostatic cancer: is there a correlation with clinical stage, Gleason grade, PSA value or age?
Bastian PJ; Ellinger J; Schmidt D; Wernert N; Wellmann A; Müller SC; von Rücker A
Eur J Med Res; 2004 Nov; 9(11):523-7. PubMed ID: 15649863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]